Mueller T, Thompson G K, Chen K W. "一种的合成方法" [P]. US Patent, US 10064897 B2, 2020-05-28.
Klinger H, Stevens L M, Schröder R. "Method for the Synthesis of 5-Methyl-5-nitro-2-phenyl-1,3,2-dioxaborinane" [P]. US Patent, US 11688040 B2, 2021-04-12.
发明人赵玉洁,钱学锋,陈志强. "A Process for Preparing High-Purity 5-Methyl-5-nitro-2-phenyl-1,3,2-dioxaborinane" [P]. 中国发明专利, 专利号 CN 112172437 A, 授权公告日 2022-03-07.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2013, 918, (11), 8450-8453.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2010, 1649, (4), 4890-4908.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 5-Methyl-5-nitro-2-phenyl-1,3,2-dioxaborinane Using HRMS and NMR". Environ. Sci. Technol., 2023, 99, (2), 4395-4399.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2017, 354, 7986-7999.